Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?
Hörl
Walter H
WH
Division of Nephrology and Dialysis, Department of Medicine III, Vienna, Austria. walter.hoerl@meduniwien.ac.at
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000401:mortality* / Q000517:prevention & control*; D015984:Causality; D015897:Comorbidity; D003374:Coumarins / Q000008:administration & dosage*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000517:prevention & control*; D015995:Prevalence; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D020521:Stroke / Q000401:mortality* / Q000517:prevention & control*; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome
D000925:Anticoagulants; D003374:Coumarins